Evidence map›Paper›PMID 41604386›Full record

ArticlePloS one2026

Culture media affects accuracy of prediction of metallo-β-lactamases mediated resistance to imipenem.

Kexuan Chen, Sarah Miller, Kristine Goy, Tina Lam, Marlène Maeusli, Rosemary She, Brad Spellberg, Brian Luna

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kexuan ChenDepartment of Immunology and Immune Therapeutics, Keck School of Medicine at USC, Los Angeles, California, United States of America.
Sarah MillerDepartment of Immunology and Immune Therapeutics, Keck School of Medicine at USC, Los Angeles, California, United States of America.
Kristine GoyDepartment of Immunology and Immune Therapeutics, Keck School of Medicine at USC, Los Angeles, California, United States of America.
Tina LamDepartment of Immunology and Immune Therapeutics, Keck School of Medicine at USC, Los Angeles, California, United States of America.
Marlène MaeusliDepartment of Immunology and Immune Therapeutics, Keck School of Medicine at USC, Los Angeles, California, United States of America.
Rosemary SheDepartment of Pathology, City of Hope, Duarte, California, United States of America.
Brad SpellbergLos Angeles General Medical Center, Los Angeles, California, United States of America.
Brian LunaDepartment of Immunology and Immune Therapeutics, Keck School of Medicine at USC, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0001-6718-4551

Funding

Identifying Synergistic Rifabutin-Containing Combinations Against A. baumanniiR01AI179046 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Brian Michael Luna · 2024 to 2026
$1.4M
NIAID NIH HHS R01 AI179046
6 · The paper itself

Abstract

Metallo-β-lactamases (MBLs) hydrolyze the beta-lactam ring in beta-lactam antibiotics, rendering them ineffective. Infections caused by MBL-harboring bacteria result in higher mortality, more costs and prolonged hospital stays due to the limited treatment options. Recently, antimicrobial susceptibility testing using RPMI-1640 has been found to have more accuracy in predicting in vivo efficacy due to its zinc deficiency. We sought to expand the previous studies of accessing in vivo efficacy using zinc-limited media versus conventional media to more antimicrobial agents and MBL-producing strains. The susceptibility of isolates was determined by performing minimum inhibitory concentration (MIC) assays using traditional cation-adjusted Mueller Hinton broth (CAMHB) or zinc-limited media. In vivo outcomes were evaluated using the Galleria mellonella infection model and neutropenic mouse thigh infection model. The MICs of MBL-harboring strains decreased in zinc-limited media compared to in nutrient-rich media, suggesting susceptibility of a subset of resistant strains when tested in zinc-limited media. Notably, we observed statistically significant MICs decreasing against imipenem, which demonstrated the best efficacy among the six tested antibiotics. Additionally, the outcomes of in vivo tests in both the G. mellonella model and the mouse model were better predicted with in vitro MIC assays performing in zinc-limited media. The use of zinc-limited media may lead to increased accuracy of the prediction of in vivo efficacy of beta-lactams against MBL-harboring bacteria.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCulture MediaImipenemAnimalsbeta Lactam AntibioticsFemaleHumansMiceMicrobial Sensitivity TestsZincAnti-Bacterial Agentsbeta Lactam Antibioticsbeta-LactamasesCulture MediaImipenemZinc

Identifiers

PMID41604386
PMCPMC12851486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.